Friday, May 29, 2015

Chemical found in stinging nettles and ants could improve cancer drug

›
A cancer drug could be made 50 times more effective by a chemical found in stinging nettles and ants, new research f...
Thursday, May 28, 2015

Olive ingredients may prevent Alzheimer's disease

›
It has long been proven that people who follow a Mediterranean diet and keep physically and mentally active are less likely to suffer...
Wednesday, May 27, 2015

New anti-clotting therapy no better than established anticoagulants

›
A novel therapy that would allow doctors to turn the body's blood-clotting ability off and on in a more controlled way was about a...
Tuesday, May 26, 2015

Viagra can have anti-cancer, anti-Alzheimer's disease effects if used with new drugs

›
Chaperone proteins play an important role in protein folding in human cells and in bacteria and are promising new targets for drugs to tre...
Monday, May 25, 2015

Promising new natural treatment for Alzheimer's disease nears clinical trial

›
  A promising new natural treatment for Alzheimer's disease is moving toward clinical trials. This will ...
Friday, May 22, 2015

Naproxen and omeprazole combination effective in preventing bladder cancer

›
The anti-inflammatory class of drugs NSAIDs have shown great promise in preventing cancers including colon, esophagus and skin. However, t...
Thursday, May 21, 2015

New drug shows promise in driving insulin-producing beta cells to multiply

›
In a screen of more than 100,000 potential drugs, only one, harmine, drove human insulin-producing beta cells to multiply, according to a ...
Wednesday, May 20, 2015

New injectable polymer could strengthen blood clots

›
In the initial study with rats, 100 per cent of animals injected with PolySTAT survived a typically lethal injury to the femoral art...
Tuesday, May 19, 2015

New cancer drug enters phase I clinical trials in humans

›
"Even though they have elevated levels of procaspase-3, cancer cells never turn the enzyme on. So they keep growing and become tumo...
Monday, May 18, 2015

EMA extends approval of Vectibix plus FOLFIRI as first-line treatment for wild-type RAS mCRC

›
Amgen (NASDAQ: AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)...
Friday, May 15, 2015

EMA's CHMP backs JINARC (tolvaptan) for autosomal dominant polycystic kidney disease

›
Tolvaptan  ( INN ), also known as OPC-41061, is a selective,  competitive   vasopressin receptor 2 antagonist  used to treat  hypona...
Thursday, May 14, 2015

Study shows efficacy of YONDELIS (trabectedin) in patients with soft-tissue sarcoma

›
In continuation of my update on  trabectedin PharmaMar announced that the  European Journal of Cancer  published online data from...
Wednesday, May 13, 2015

Bionomics to present data from DisrupTOR-1 trial at ASCO Genitourinary Cancers Symposium

›
Bionomics Limited (ASX:BNO, ADR:BMICY) is to present important additional data from the DisrupTOR-1 trial of BNC105 in patients wi...
Tuesday, May 12, 2015

Sorafenib, sunitinib provide no benefit to patients with locally advanced kidney cancer

›
Findings from a federally funded study suggest that patients with locally advanced kidney cancer should not be treated with either adjuvan...

Treatment reduces risk of recurrence of C. difficile infection

›
In continuation of my update on  metronidazole  &   vancomycin Among patients with  Clostridium  difficile   infection (CDI) wh...